FNY Investment Advisers’s Annovis Bio ANVS Stock Holding History

FNY Investment Advisers’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,000	Closed	-$2K	–	856
2026 Q1	$2K	Sell	1,000 -1,000	-50%	-$2.74K	﹤0.01%	655
2025 Q4	$6K	Hold	2,000	–	–	﹤0.01%	706
2025 Q3	$4K	Buy	+2,000	New	+$5K	﹤0.01%	941
2024 Q2	–	Sell	-400	Closed	-$4K	–	444
2024 Q1	$4K	Sell	400 -200	-33%	-$2.18K	﹤0.01%	529
2023 Q4	$11K	Sell	600 -533	-47%	-$4.73K	0.01%	301
2023 Q3	$10K	Buy	+1,133	New	+$14K	0.01%	383
2022 Q3	–	Sell	-3,650	Closed	-$41K	–	640
2022 Q2	$41K	Buy	3,650 +3,050	+508%	+$33.3K	0.03%	248
2022 Q1	$8K	Buy	+600	New	+$8.67K	0.01%	481

Other funds holding ANVS

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

FNY Investment Advisers's ANVS Position: Q2 2026 in Review

FNY Investment Advisers sold out of Annovis Bio (ANVS) in Q2 2026, closing a stake of 1,000 shares — an estimated $2K sold.

FNY Investment Advisers first reported a position in ANVS in Q1 2022 and held it in 8 quarters. The position peaked at $41K in Q2 2022. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

FNY Investment Advisers reported no remaining Annovis Bio position as of Q2 2026 after selling out during the quarter.
FNY Investment Advisers sold 1,000 Annovis Bio shares in Q2 2026, an estimated $2K.
FNY Investment Advisers first reported a position in Annovis Bio in Q1 2022 and held it in 8 quarters.
FNY Investment Advisers's Annovis Bio position peaked at $41K in Q2 2022.
61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.